AH
ORIC icon

Andreas Halvorsen’s Oric Pharmaceuticals ORIC Stock Holding History

Andreas Halvorsen’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.5M Sell
5,126,762
-697,771
-12% -$6.33M 0.16% 73
2026
Q1 		$73.8M Sell
5,824,533
-748,158
-11% -$8.49M 0.21% 68
2025
Q4 		$53.8M Sell
6,572,691
-9
-0% -$104 0.14% 72
2025
Q3 		$78.9M Hold
6,572,700
– – 0.2% 67
2025
Q2 		$66.7M Hold
6,572,700
– – 0.19% 73
2025
Q1 		$36.7M Buy
6,572,700
+2,141,692
+48% +$18.7M 0.12% 78
2024
Q4 		$35.8M Buy
4,431,008
+431,008
+11% +$3.95M 0.12% 77
2024
Q3 		$41M Hold
4,000,000
– – 0.15% 75
2024
Q2 		$28.3M Hold
4,000,000
– – 0.11% 75
2024
Q1 		$55M Buy
+4,000,000
New +$47.5M 0.2% 71

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIHC Capital Management Central $104M AUM

Andreas Halvorsen's ORIC Position: Q2 2026 in Review

Andreas Halvorsen reduced its Oric Pharmaceuticals (ORIC) stake by 12% in Q2 2026, selling an estimated $6.33M and leaving 5,126,762 shares worth $55.5M. The position accounts for 0.16% of the portfolio, ranked #73.

Andreas Halvorsen first reported a position in ORIC in Q1 2024 and has held it in 10 quarters since. The position peaked at $78.9M in Q3 2025. 179 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Andreas Halvorsen held 5,126,762 shares of Oric Pharmaceuticals worth $55.5M as of Q2 2026.
  • Andreas Halvorsen sold 697,771 Oric Pharmaceuticals shares in Q2 2026, an estimated $6.33M.
  • Oric Pharmaceuticals made up 0.16% of Andreas Halvorsen's portfolio in Q2 2026, its #73 holding.
  • Andreas Halvorsen first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Andreas Halvorsen's Oric Pharmaceuticals position peaked at $78.9M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Viking Global Investors's 13F filing for Q2 2026, filed 14 Aug 2026.